查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032976

連續血糖監測系統市場規模、佔有率、趨勢和預測：按組件、人口統計、最終用戶和地區分類，2026-2034 年

Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年全球持續血糖監測（CGM）市場規模為74億美元。展望未來，IMARC Group預測，該市場將以4.38%的複合年成長率從2026年成長至2034年，到2034年達到110億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過38.7%。推動持續血糖監測系統市場佔有率成長的因素包括：人們對CGM設備的認知度和使用率不斷提高、糖尿病盛行率上升、CGM設備技術的顯著進步以及預防醫學的持續發展。

持續血糖監測系統 (CGMS) 是一種技術先進的設備，可自動追蹤血糖值。它由一個整合發射器和發送器的裝置組成，該感測器透過經皮或皮下途徑工作，持續測量組織間液中的葡萄糖濃度。發送器將訊息傳送到可夾在衣服上的無線監測器。 CGMS 提供全面的糖尿病概況，提醒患者血糖值過高或過低，檢測血糖模式，並幫助他們更好地了解自己的運動、用藥選擇、飲食和壓力水平。與傳統血糖儀相比，CGMS 無需穿刺，因為它佩戴在皮膚上，並且能夠快速、無痛地提供即時資訊。

連續血糖監測系統市場趨勢：

全球老年人口的不斷成長使得糖尿病患病風險增加，為市場帶來了良好的前景。動態血糖監測系統（CGMS）常用於測量體內血糖值和胰島素水平，並在數值過低或過高時發出警報。即時識別低血糖和高血糖產品的日益普及正在推動市場成長。此外，CGMS技術的顯著改進和新技術進步，尤其是在輔助檢測糖尿病患者糖化血紅蛋白（HbA1c）方面，也大大促進了市場成長。 CGMS技術與人工胰臟系統（透過注射胰島素來控制患者血糖值並提供最佳劑量）的結合，也對市場成長產生了積極影響。此外，非侵入式CGMS設備的推出作為便捷的替代方案、廣泛的研發活動以及對微創診斷工具日益成長的需求，預計都將進一步推動市場成長。

市場區隔:

本報告分析了全球連續血糖監測系統市場各細分領域的關鍵趨勢，並對2026年至2034年進行了全球、區域和國家層面的預測。市場按其組成部分、人口統計和最終用戶進行細分。

依組成部分分解：

  • 感應器
  • 發送器和接收器
  • 整合式胰島素泵

按人口統計特徵分類：

  • 兒童人口（14歲以下）
  • 成年人口（15歲以上）

按最終用戶細分：

  • 診所和診斷中心
  • 加護病房
  • 居家醫療

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

關於該行業的競爭格局，我們調查了該行業的競爭環境，以及主要公司的概況，例如 A. Menarini Diagnostics Srl、Abbott Laboratories、DexCom Inc.、F. Hoffmann-La Roche AG、Glysens Incorporated、LifeScan Inc.（強生公司）、Medtronic Inc. Waveform Technologies Inc.。

本報告解答的主要問題

1. 連續血糖監測系統市場規模有多大？

2. 連續血糖監測系統市場的未來前景如何？

3. 持續血糖監測系統市場的主要促進因素是什麼？

4. 在連續血糖監測系統市場中，哪個地區佔據最大的市佔率？

5. 全球緩釋血糖監測系統市場的主要參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球連續血糖監測系統市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依組件分類

  • 感應器
  • 發送器和接收器
  • 整合式胰島素泵

第7章 市場區隔：依人口統計資料分類

  • 兒童人口（14歲以下）
  • 成年人口（15歲以上）

第8章 市場區隔：依最終用戶分類

  • 診所和診斷中心
  • ICU
  • 家庭醫療保健

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc.（Johnson & Johnson）
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112026A5377

The global continuous glucose monitoring systems market size was valued at USD 7.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.0 Billion by 2034, exhibiting a CAGR of 4.38% from 2026-2034. North America currently dominates the market, holding a market share of over 38.7% in 2025. The increasing awareness and adoption of CGM devices, rising prevalence of diabetes, significant technological advancements in CGM devices, and ongoing shift towards preventive healthcare are some of the factors boosting the continuous glucose monitoring systems market share.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Market Segmentation:

This report provides an analysis of the key trends in each segment of the global continuous glucose monitoring systems market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on the component, demographics, and end user.

Breakup by Component:

  • Sensors
  • Transmitters and Receivers
  • Integrated Insulin Pumps

Breakup by Demographics:

  • Child Population (<=14 years)
  • Adult Population (>14 years)

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

1. How big is the continuous glucose monitoring systems market?

2. What is the future outlook of continuous glucose monitoring systems market?

3. What are the key factors driving the continuous glucose monitoring systems market?

4. Which region accounts for the largest continuous glucose monitoring systems market share?

5. Which are the leading companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transmitters and Receivers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Demographics

  • 7.1 Child Population (<=14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2025
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2025
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million USD), 2026-2034
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million USD), 2026-2034
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players